Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01744691
Brief Title: A Multicenter Phase 2 Study of Ibrutinib in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) With 17p Deletion

First Submitted : December 3, 2012
First Submitted that Met QC Criteria : December 6, 2012
First Posted : December 7, 2012 (Estimate)

Results First Submitted : May 21, 2015
Results First Submitted that Met QC Criteria : May 21, 2015
Results First Posted : June 9, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : January 9, 2017
Last Update Posted : February 27, 2017